Radiographic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer

被引：0

作者：

Siravegna, Giulia ^{[1
]}

Lazzari, Luca ^{[1
]}

Sartore-Bianchi, Andrea ^{[2
]}

Crisafulli, Giovanni ^{[1
]}

Mussolin, Benedetta ^{[1
]}

Cassingena, Andrea ^{[2
]}

Martino, Cosimo ^{[1
]}

Lanman, Richard ^{[3
]}

Nagy, Rebecca ^{[3
]}

Corti, Giorgio ^{[1
]}

Bartolini, Alice ^{[1
]}

Arcella, Pamela ^{[1
]}

Montone, Monica ^{[1
]}

Lodi, Francesca ^{[1
]}

Vanzati, Alice ^{[2
]}

Valtorta, Emanuele ^{[2
]}

Cappello, Giovanni ^{[1
]}

Bertotti, Andrea ^{[1
]}

Lonardi, Sara ^{[4
]}

Zagonel, Vittorina ^{[4
]}

Leone, Francesco ^{[1
]}

Russo, Mariangela ^{[1
]}

Balsamo, Antonella ^{[1
]}

Truini, Mauro ^{[2
]}

Di Nicolantonio, Federica ^{[1
]}

Amatu, Alessio ^{[2
]}

Bonazzina, Erica ^{[2
]}

Ghezzi, Silvia ^{[2
]}

Regge, Daniele ^{[1
]}

Vanzulli, Angelo ^{[2
]}

Trusolino, Livio ^{[1
]}

Siena, Salvatore ^{[2
]}

Marsoni, Silvia ^{[1
]}

Bardelli, Alberto ^{[1
]}

机构：

[1] Inst Canc Res & Treatment, Candiolo, Italy

[2] Grande Osped Metropolitano Niguarda, Milan, Italy

[3] Guardant Hlth, Redwood City, CA USA

[4] IRCCS, Ist Oncol Veneto, Padua, Italy

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-2848

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2848

引用

页数：2

共 50 条

[31] Her2/Neu (HER2) Intratumoral Genetic Heterogeneity in Breast Cancer and Its Concurrent Axillary Metastases
Astvatsaturyan, K.
Bose, S.
LABORATORY INVESTIGATION, 2013, 93 : 28A - 28A
[32] Her2/Neu (HER2) Intratumoral Genetic Heterogeneity in Breast Cancer and Its Concurrent Axillary Metastases
Astvatsaturyan, K.
Bose, S.
MODERN PATHOLOGY, 2013, 26 : 28A - 28A
[33] Pertuzumab: Optimizing HER2 Blockade
Metzger-Filho, Otto
Winer, Eric P.
Krop, Ian
CLINICAL CANCER RESEARCH, 2013, 19 (20) : 5552 - 5556
[34] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
Wei, T.
Wang, D.
Peng, Y.
ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302
[35] Sparing chemotherapy with dual HER2 blockade in combination with endocrine therapy for advanced HER2 positive breast cancer
Werutsky, Gustavo
Reinert, Tomas
Fay, Andre Poisl
TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S573 - S576
[36] Brain metastases: The HER2 paradigm
Lin, Nancy U.
Winer, Eric P.
CLINICAL CANCER RESEARCH, 2007, 13 (06) : 1648 - 1655
[37] Expression of HER2 in colorectal cancer does not correlate with prognosis
Kruszewski, Wieslaw Janusz
Rzepko, Robert
Ciesielski, Maciej
Szefel, Jaroslaw
Zielinski, Jacek
Szajewski, Mariusz
Jasinski, Wojciech
Kawecki, Krzysztof
Wojtacki, Janusz
DISEASE MARKERS, 2010, 29 (05) : 207 - 212
[38] Combinatorial blockade of ERBB receptors in HER2 low breast cancer
Berdiel-Acer, Mireia
Reinz, Eileen
Abnaof, Khalid
Burmester, Sara
Will, Rainer
Korf, Ulrike
Wiemann, Stefan
CANCER RESEARCH, 2017, 77
[39] Targeted therapy for HER2 driven colorectal cancer.
Ross, Jeffrey S.
Ali, Siraj Mahamed
Elvin, Julia Andrea
Schrock, Alexa Betzig
Suh, James
Vergilio, Jo-Anne
Ramkissoon, Shakti
Severson, Eric Allan
Daniel, Sugganth
Fabrizio, David
Frampton, Garrett Michael
Miller, Vincent A.
Stephens, Philip J.
Gay, Laurie M.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[40] Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
Blok, Erik J.
Kuppen, Peter J. K.
van Leeuwen, Jeroen E. M.
Sier, Cornelis F. M.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 41 - 51

← 1 2 3 4 5 →